Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
John A. Smith(Cleveland Metropolitan School District), Sean Parker(Northumbria Healthcare NHS Foundation Trust), J. Holcomb, David Elkayam(Merck & Co., Inc., Rahway, NJ, USA (United States)), John J. Condemi(Baylor College of Medicine), Eric Schenkel, Jonathan Corren(California Allergy and Asthma Medical Group), Lorcan McGarvey(Queen's University Belfast), Faisal Fakih, Thomas Murphy(Manchester Academic Health Science Centre), Alyn H. Morice(Castle Hill Hospital), Leon S. Greos, Ellen Sher, Mark H. Gotfried(Pulmonary Associates), Surinder S. Birring(King's College Hospital), Iftikhar Hussain(City University of Hong Kong), James Krainson, Shaila U Gogate, James H. Hull(Royal Brompton Hospital), Anthony Ford(Sunesis (United States)), Thomas B. Casale(University of South Florida), Jason Friesen, Jonathan Matz, Zhi Jin Xu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alan B. Goldsobel, Krishna M. Sundar, Selwyn Spangenthal, David I. Bernstein(Cincinnati Children's Hospital Medical Center), William R. Lumry(The University of Texas Southwestern Medical Center), William W. Storms(University of Pittsburgh), Yuping Li(Guangdong Province Women and Children Hospital), Wen‐Chi Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael Kaplan(Duke University), Anthony Montanaro(Merck & Co., Inc., Rahway, NJ, USA (United States)), Warner Carr(Asthma Association), Michael M. Kitt(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gary Berman, Gregory Daniel Brooks, David Muccino(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mandel Sher(Florida Center for Gastroenterology), Gary N. Gross, Gary C. Steven, Niran J. Amar, James Good(Queen Elizabeth Hospital Birmingham), Bruce M. Prenner
Cited by 224
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Lebrikizumab Treatment in Adults with Asthma
|New England Journal of Medicine|2011|1.5k
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
|Journal of Allergy and Clinical Immunology|2011|1.2k